(Last update on 3 July 2013)
Room: Franz-Patat-Hörsaal (3rd floor)
| 08:30 | Opening and Introduction |
|
VIRUS REPLICATION AT THE INTERCELLULAR LEVEL |
|
| 08:50 |
Keynote |
| 09:30 | Mathematical modeling of the intracellular hepatitis C virus replication L. Kaderali, M. Binder, N. Sulaimanov, D. Clausznitzer, M. Schulze, C.M. Hüber, S.M. Lenz, J.P. Schlöder, M. Trippler, R. Bartenschlager, V. Lohmann, TU Dresden/D |
| 10:00 | Coffee Break |
|
MODELS OF SIMPLE IN VITRO VIRAL INFECTION SYSTEMS I |
|
| 10:20 | Keynote Modeling influenza A viral infections in vitro C.A.A. Beauchemin, Ryerson University, Toronto, ON/CDN |
| 11:00 | Multi-scale modeling of influenza virus infection elucidates the performance of antivirals F.S. Heldt, B. Isken, A. Pflugmacher, T. Frensing, Max Planck Institute for Dynamics of Complex Technical Systems, Magdeburg/D; U. Reichl, Max Planck Institute for Dynamics of Complex Technical Systems and Otto von Guericke University Magdeburg/D |
| 11:30 | Cell cycle based calculations of the in vitro baculovirus life cycle C. Lindenberger, FAU Busan/ROK; R. Buchholz, Universität Erlangen-Nürnberg/D |
| 12:00 | Lunch Break |
| MODELS OF SIMPLE IN VITRO VIRAL INFECTION SYSTEMS II Chair: C.A.A. Beauchemin, Ryerson University, Toronto, ON/CDN |
|
| 13:30 | Keynote Population balance modeling of influenza virus replication during vaccine production A. Kienle, Max Planck Institute for Dynamics of Complex Technical Systems and Otto von Guericke University Magdeburg/D |
| 14:10 | Spatial virus dynamics and the spread of oncolytic viruses D. Wodarz, A. Hofacre, Z. Sun, H. Fan, N. Komarova, J. Lau, University of California, Irvine, CA/USA |
| 14:40 | Mathematical modeling of cell culture experiment reveals a critical difference among viral strains - A case study of simian/human immunodeficiency virus (SHIV)S. Iwami, Kyushu University, Fukuoka/J; R. de Boer, Utrecht University/NL; Y. Koizumi, Kanazawa University/J; T. Igarashi, T. Miura, Kyoto University/J |
| 15:10 | SHORT POSTER PRESENTATIONS |
| 15:55 | Coffee Break |
| IN VIVO MODELING AND HOW TO IMPLEMENT THE IMMUNE RESPONSE I Chair: A.S. Perelson, Los Alamos National Laboratory, NM/USA |
|
| 16:30 | Keynote How to further improve our models - some thoughts A. Handel, University of Georgia, Athens, GA/USA |
| 17:10 |
Assessing mathematical models of influenza infections using features of the immune response |
| 17:40 | Kinetics of influenza coinfection in mice A. Smith, St. Jude Children's Research Hospital, Memphis, TN/USA; F. Adler, University of Utah, Salt Lake City, UT/USA; R. Ribeiro, Los Alamos National Laboratory, NM/USA; R. Gutenkunst, University of Arizona, Tucson, AZ/USA; J. McAuley, University of Melbourne, VIC/AUS; J. McCullers, St. Jude Children's Research Hospital, Memphis, TN/USA; A. Perelson, Los Alamos National Laboratory, NM/USA |
| 18:10 | End of the conference day |
| 20:00 - 22:00 |
Conference Dinner - registration required |
Room: Franz-Patat-Hörsaal (3rd floor)
|
IN VIVO MODELING AND HOW TO IMPLEMENT THE IMMUNE RESPONSE II |
|
| 08:50 | Keynote Modeling the battle between virus and host defense on varied terrain T. Höfer, German Cancer Research Center (DKFZ), Heidelberg/D |
| 09:30 |
The effects of aging on influenza virus infection dynamics |
| 10:00 | Coffee Break |
| IN VIVO MODELING AND HOW TO IMPLEMENT THE IMMUNE RESPONSE III Chair: H. Dahari, Loyola Univeristy Chicago, Maywood, IL/USA and Los Alamos National Laboratory, NM/USA |
|
| 10:20 | Keynote Modeling HCV infection in vivo A.S. Perelson, Los Alamos National Laboratory, NM/USA |
| 11:00 | Modeling the immune response dynamics following hepatitis B virus infection S. Ciupe, Virginia Tech, Blacksburg, VA/USA |
| 11:30 | Inferring viral dynamics in chronically HCV infected patients from the spatial distribution of infected hepatocytes F. Graw, Heidelberg University/D; A. Balagopal, S. Ray, A. Kandathil, D.L. Thomas, Johns Hopkins University, Baltimore, MD/USA; R.M. Ribeiro, A.S. Perelson, Los Alamos National Laboratory, NM/USA |
| 12:00 | Lunch Break |
| 13:30 | Modeling early viral kinetics with alisporivir: interferon-free treatment and SVR predictions in HCV G2/3 patients J. Guedj, INSERM U738, Paris/F; J. Yu, Novartis, Cambridge, MA/USA; M. Levi, Novartis, East Hannover, NJ/USA; B. Li, Novartis, Cambridge, MA/USA; S. Kern, N. Naoumov, Novartis, Basel/CH; A.S. Perelson, Los Alamos National Laboratory, NM/USA |
| 14:00 | dsRNA recognition by the RIG-I innate immunity pathway D. Clausznitzer, TU Dresden/D; M. Binder, University of Heidelberg/D; T. Becker, University of Mainz/D; F. Eberle, R. Bartenschlager, University of Heidelberg/D; L. Kaderali, TU Dresden/D |
| 14:30 | Coffee Break |
| COMPUTATIONAL TOOLS AND THEORETICAL ASPECTS Chair: A. Handel, University of Georgia, Athens, GA/USA |
|
| 14:50 | Keynote Modeling immune responses to viral infections at multi-scale system levels: inverse problems for both model structures and parameters |
Last minute change |
| 15:50 | WRAP-UP |
| 16:10 | End of the conference |
| 17:00 | Guided walking tour of Frankfurt - registration required (click here for more information) |